These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Comparison of cefamandole nafate to cefamandole by microbiological assay. Winely CL; Spears JC; Scott JK Antimicrob Agents Chemother; 1979 Sep; 16(3):424-6. PubMed ID: 41479 [TBL] [Abstract][Full Text] [Related]
4. Hydrolysis of cefamandole nafate to cefamandole in vivo. Wold JS; Joost RR; Black HR; Griffith RS J Infect Dis; 1978 May; 137 Suppl():S17-S24. PubMed ID: 650001 [TBL] [Abstract][Full Text] [Related]
5. Delineation of the relative antibacterial activity of cefamandole and cefamandole nafate. Turner JR; Preston DA; Wold JS Antimicrob Agents Chemother; 1977 Jul; 12(1):67-72. PubMed ID: 18988 [TBL] [Abstract][Full Text] [Related]
6. Stability of cefamandole nafate and cefoxitin sodium solutions. Das Gupta V; Stewart KR Am J Hosp Pharm; 1981 Jun; 38(6):875-9. PubMed ID: 7246563 [TBL] [Abstract][Full Text] [Related]
7. Cefamandole---a review of chemistry and microbiology. Kaiser GV; Gorman M; Webber JA J Infect Dis; 1978 May; 137 Suppl():S10-S16. PubMed ID: 565798 [TBL] [Abstract][Full Text] [Related]
8. Stability of frozen solutions of cefamandole nafate. Bornstein M; Klink PR; Farrell BT; Winely CL; Boylan JC Am J Hosp Pharm; 1980 Jan; 37(1):98-101. PubMed ID: 7361780 [TBL] [Abstract][Full Text] [Related]
9. Hydrolysis of cefamandole nafate in dialysis patients. Nielsen RL; Wolen R; Luft FC; Ozawa T Antimicrob Agents Chemother; 1979 Nov; 16(5):683-5. PubMed ID: 526012 [TBL] [Abstract][Full Text] [Related]
10. Effect of cefamandole nafate on the toxicity of tobramycin. Wold JS; Turnipseed SA; Broddle WD; Owen NV Antimicrob Agents Chemother; 1977 Oct; 12(4):465-9. PubMed ID: 921240 [TBL] [Abstract][Full Text] [Related]
11. [Cefamandole: in vitro and in vivo activity]. Martinetto P; Valtz A; Cavallo GP; Angeretti A G Batteriol Virol Immunol; 1979; 72(1-6):44-61. PubMed ID: 553842 [TBL] [Abstract][Full Text] [Related]
13. Bioavailability and pain study of cefamandole nafate. Foster TS; Shrewsbury RP; Coonrod JD J Clin Pharmacol; 1980; 20(8-9):526-33. PubMed ID: 7000857 [TBL] [Abstract][Full Text] [Related]
14. Chemical stabilities of cefamandole nafate and metronidazole when mixed together for intravenous infusion. Das Gupta V; Stewart KR; Dela Torre M J Clin Hosp Pharm; 1985 Dec; 10(4):379-83. PubMed ID: 4093509 [TBL] [Abstract][Full Text] [Related]
15. Orally active esters of cephalosporin antibiotics. II. Synthesis and biological properties of the acetoxymethyl ester of cefamandole. Wright WE; Wheeler WJ; Line VD; Frogge JA; Finley DR J Antibiot (Tokyo); 1979 Nov; 32(11):1155-60. PubMed ID: 528384 [TBL] [Abstract][Full Text] [Related]
16. Stability of cefamandole nafate injection with parenteral solutions and additives. Frable RA; Klink PR; Engel GL; Mundell EE Am J Hosp Pharm; 1982 Apr; 39(4):622-7. PubMed ID: 7082453 [No Abstract] [Full Text] [Related]
18. A note on the effect of gamma-rays on cefamandole and oxacillin. Jacobs GP; Dobrilovic L; Raghavan N; Carpenter D Int J Rad Appl Instrum A; 1987; 38(1):71-3. PubMed ID: 3030972 [TBL] [Abstract][Full Text] [Related]
19. Stability of clindamycin phosphate and ceftizoxime sodium, cefoxitin sodium, cefamandole nafate, or cefazolin sodium in two intravenous solutions. Bosso JA; Townsend RJ Am J Hosp Pharm; 1985 Oct; 42(10):2211-4. PubMed ID: 3864367 [TBL] [Abstract][Full Text] [Related]